Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1, and removed the government funding status notice about potential delays.
    Difference
    0.3%
    Check dated 2026-02-11T04:40:46.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and potential delays, with status links; updated the site version to v3.4.1 (from v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T04:15:20.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated several labels and version text, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older phrasing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T01:24:08.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears replacing v3.3.3; no substantive content or functional changes to the study details are evident in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:35:38.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The Locations section was added and now lists California, Florida, Georgia, Indiana, Maryland, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, and Pennsylvania, with the revision tag updated to v3.3.3. Previous location subpages (e.g., California Locations, Florida Locations, etc.) were removed, and the HHS Vulnerability Disclosure link was removed.
    Difference
    1%
    Check dated 2025-12-23T17:15:30.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    A new revision label "Revision: v3.3.2" was added and the previous "Revision: v3.2.0" label was removed.
    Difference
    0.0%
    Check dated 2025-11-24T21:26:33.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.